Furthermore in vitro analyses have shown that miR-126 overexpression in the NSCLC line cell inhibits cell growth through different gene targets, including CRK, EGFL7 and PIK3R2 [67–69]. The gene discussed is CRK; the disease is non-small cell lung carcinoma.